United States

Rocky Swift

Japan drug price reforms risk hurting investment: Bristol-Myers CEO

Oct 03 2019

TOKYO Japan's "overly restrictive" drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday.

French drugmaker Sanofi to cut about 200 jobs in Japan: source

Sep 30 2019

TOKYO French drugmaker Sanofi SA plans to cut about 200 jobs in Japan across sales, regulatory affairs and operations, a person familiar with the matter said, months after the company said it would shed nearly 500 jobs in France and Germany.

Sumitomo Dainippon Pharma investing $3 billion in Swiss Roivant in overseas push

Sep 06 2019

TOKYO Japan's Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its biopharmaceutical businesses, the two companies said on Friday.

World News